Bryan M. Curtis

640 total citations
14 papers, 467 citations indexed

About

Bryan M. Curtis is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Bryan M. Curtis has authored 14 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 5 papers in Cardiology and Cardiovascular Medicine and 3 papers in Genetics. Recurrent topics in Bryan M. Curtis's work include Dialysis and Renal Disease Management (9 papers), Meta-analysis and systematic reviews (3 papers) and Erythropoietin and Anemia Treatment (3 papers). Bryan M. Curtis is often cited by papers focused on Dialysis and Renal Disease Management (9 papers), Meta-analysis and systematic reviews (3 papers) and Erythropoietin and Anemia Treatment (3 papers). Bryan M. Curtis collaborates with scholars based in Canada and United States. Bryan M. Curtis's co-authors include Robert N. Foley, Edward Randell, Patrick S. Parfrey, Patrick S. Parfrey, Adeera Levin, Patrick S. Parfrey, Ognjenka Djurdjev, F. Malberti, Paul A. Taylor and Pietro Ravani and has published in prestigious journals such as American Journal of Kidney Diseases, Clinical Journal of the American Society of Nephrology and Nephrology Dialysis Transplantation.

In The Last Decade

Bryan M. Curtis

14 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bryan M. Curtis Canada	7	314	130	90	55	53	14	467
Leslie J. Ng United States	5	276 0.9×	42 0.3×	72 0.8×	84 1.5×	41 0.8×	9	390
Amedeo F. De Vecchi Italy	12	290 0.9×	32 0.2×	76 0.8×	47 0.9×	87 1.6×	26	496
Kyu Bok Choi South Korea	14	243 0.8×	108 0.8×	26 0.3×	71 1.3×	53 1.0×	30	426
Jung‐Hwa Ryu South Korea	12	248 0.8×	89 0.7×	25 0.3×	60 1.1×	39 0.7×	29	443
Francisco Coronel Spain	14	318 1.0×	42 0.3×	68 0.8×	73 1.3×	33 0.6×	60	548
Radhika Kanthety United States	7	187 0.6×	120 0.9×	54 0.6×	39 0.7×	62 1.2×	8	358
WH Herman United States	3	284 0.9×	114 0.9×	31 0.3×	68 1.2×	42 0.8×	9	473
J. M. López‐Gómez Spain	8	233 0.7×	31 0.2×	41 0.5×	68 1.2×	31 0.6×	14	462
Olivera Stojceva-Taneva North Macedonia	11	284 0.9×	59 0.5×	26 0.3×	88 1.6×	35 0.7×	41	447
Alex W. Yu China	12	529 1.7×	81 0.6×	68 0.8×	77 1.4×	70 1.3×	24	716

Countries citing papers authored by Bryan M. Curtis

Since Specialization

Citations

This map shows the geographic impact of Bryan M. Curtis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan M. Curtis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan M. Curtis more than expected).

Fields of papers citing papers by Bryan M. Curtis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan M. Curtis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan M. Curtis. The network helps show where Bryan M. Curtis may publish in the future.

Co-authorship network of co-authors of Bryan M. Curtis

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan M. Curtis. A scholar is included among the top collaborators of Bryan M. Curtis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan M. Curtis. Bryan M. Curtis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Curtis, Bryan M., et al.. (2018). Atypical Noncrescentic Antiglomerular Basement Membrane Disease With Concurrent Thin Basement Membrane Nephropathy. Kidney International Reports. 3(4). 991–996. 4 indexed citations

Murphy, S., et al.. (2017). Costs Associated With Intravenous Darbepoetin Versus Epoetin Therapy in Hemodialysis Patients: A Randomized Controlled Trial. Canadian Journal of Kidney Health and Disease. 4. 2245595629–2245595629. 5 indexed citations

Curtis, Bryan M., Brendan J. Barrett, & Patrick S. Parfrey. (2015). Randomized Controlled Trials 1: Design. Methods in molecular biology. 1281. 159–175. 2 indexed citations

Williams, Christopher E., Bryan M. Curtis, Edward Randell, Robert N. Foley, & Patrick S. Parfrey. (2014). Cardiac Biomarkers and Health-Related Quality of Life in New Hemodialysis Patients without Symptomatic Cardiac Disease. Canadian Journal of Kidney Health and Disease. 1. 16–16. 9 indexed citations

Foley, Robert N., Bryan M. Curtis, Edward Randell, & Patrick S. Parfrey. (2010). Left Ventricular Hypertrophy in New Hemodialysis Patients without Symptomatic Cardiac Disease. Clinical Journal of the American Society of Nephrology. 5(5). 805–813. 125 indexed citations

Foley, Robert N., Bryan M. Curtis, & Patrick S. Parfrey. (2009). Erythropoietin Therapy, Hemoglobin Targets, and Quality of Life in Healthy Hemodialysis Patients. Clinical Journal of the American Society of Nephrology. 4(4). 726–733. 55 indexed citations

Curtis, Bryan M., Brendan J. Barrett, & Patrick S. Parfrey. (2008). The Design of Randomized Controlled Trials. Methods in molecular biology. 473. 95–111. 5 indexed citations

Foley, Robert N., Bryan M. Curtis, & Patrick S. Parfrey. (2008). Hemoglobin Targets and Blood Transfusions in Hemodialysis Patients without Symptomatic Cardiac Disease Receiving Erythropoietin Therapy. Clinical Journal of the American Society of Nephrology. 3(6). 1669–1675. 29 indexed citations

Curtis, Bryan M., Brendan J. Barrett, Ognjenka Djurdjev, Joel Singer, & Adeera Levin. (2007). Evaluation and Treatment of CKD Patients Before and at Their First Nephrologist Encounter in Canada. American Journal of Kidney Diseases. 50(5). 733–742. 30 indexed citations

10.

Curtis, Bryan M., Adeera Levin, & Patrick S. Parfrey. (2005). Multiple Risk Factor Intervention in Chronic Kidney Disease: Management of Cardiac Disease in Chronic Kidney Disease Patients. Medical Clinics of North America. 89(3). 511–523. 6 indexed citations

11.

Curtis, Bryan M. & Patrick S. Parfrey. (2005). Congestive Heart Failure in Chronic Kidney Disease: Disease-specific Mechanisms of Systolic and Diastolic Heart Failure and Management. Cardiology Clinics. 23(3). 275–284. 46 indexed citations

12.

Curtis, Bryan M., Pietro Ravani, F. Malberti, et al.. (2004). The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrology Dialysis Transplantation. 20(1). 147–154. 149 indexed citations

13.

Curtis, Bryan M., Brendan J. Barrett, & Patrick S. Parfrey. (2003). How to Design a Clinical Trial. Humana Press eBooks. 86. 475–490. 1 indexed citations

14.

Curtis, Bryan M. & Patrick S. Parfrey. (2002). How Can the Cardiac Death Rate be Reduced in Dialysis Patients?. Seminars in Dialysis. 15(1). 22–24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact